Caroline Samer

4.1k total citations
107 papers, 2.5k citations indexed

About

Caroline Samer is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Caroline Samer has authored 107 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Pharmacology, 28 papers in Pediatrics, Perinatology and Child Health and 18 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Caroline Samer's work include Pharmacogenetics and Drug Metabolism (39 papers), Pharmacological Effects and Toxicity Studies (21 papers) and Pharmaceutical Practices and Patient Outcomes (11 papers). Caroline Samer is often cited by papers focused on Pharmacogenetics and Drug Metabolism (39 papers), Pharmacological Effects and Toxicity Studies (21 papers) and Pharmaceutical Practices and Patient Outcomes (11 papers). Caroline Samer collaborates with scholars based in Switzerland, United States and France. Caroline Samer's co-authors include Jules Desmeules, Youssef Daali, Victoria Rollason, Pierre Dayer, Kuntheavy Ing Lorenzini, Julien Déglon, M. Rebsamen, Camille Lenoir, Thomas A. Mavrakanas and Marija Bosilkovska and has published in prestigious journals such as Hepatology, Endocrinology and The American Journal of Medicine.

In The Last Decade

Caroline Samer

100 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Caroline Samer Switzerland 28 832 440 406 352 295 107 2.5k
Yoseph Caraco Israel 27 946 1.1× 296 0.7× 270 0.7× 337 1.0× 432 1.5× 102 2.3k
Mordechai Muszkat Israel 25 550 0.7× 212 0.5× 664 1.6× 234 0.7× 332 1.1× 105 2.4k
C. Michael Stein United States 35 539 0.6× 432 1.0× 1.2k 3.1× 379 1.1× 535 1.8× 109 4.2k
Daniel Kurnik Israel 25 423 0.5× 191 0.4× 395 1.0× 192 0.5× 296 1.0× 86 1.9k
Hilary Wynne United Kingdom 28 1.5k 1.8× 361 0.8× 690 1.7× 394 1.1× 236 0.8× 76 3.5k
René Verbesselt Belgium 28 344 0.4× 787 1.8× 191 0.5× 441 1.3× 174 0.6× 95 2.3k
Denis J. Morgan Australia 28 589 0.7× 425 1.0× 187 0.5× 504 1.4× 295 1.0× 138 2.7k
Allan J. McLean Australia 29 619 0.7× 351 0.8× 344 0.8× 334 0.9× 390 1.3× 77 3.2k
Jouni Ahonen Finland 27 467 0.6× 496 1.1× 305 0.8× 245 0.7× 142 0.5× 87 2.6k
Hirotoshi Echizen Japan 28 1.2k 1.5× 337 0.8× 373 0.9× 550 1.6× 373 1.3× 100 3.0k

Countries citing papers authored by Caroline Samer

Since Specialization
Citations

This map shows the geographic impact of Caroline Samer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline Samer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline Samer more than expected).

Fields of papers citing papers by Caroline Samer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caroline Samer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline Samer. The network helps show where Caroline Samer may publish in the future.

Co-authorship network of co-authors of Caroline Samer

This figure shows the co-authorship network connecting the top 25 collaborators of Caroline Samer. A scholar is included among the top collaborators of Caroline Samer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline Samer. Caroline Samer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Terrier, Jean, Pauline Gosselin, Camille Lenoir, et al.. (2025). Virtual twin approach using physiologically based pharmacokinetic modelling in hospitalized patients treated with apixaban or rivaroxaban. British Journal of Clinical Pharmacology. 91(7). 2057–2069.
2.
Eum, Seenae, Zeruesenay Desta, Rachel F. Tyndale, et al.. (2024). Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2B6 Genotype and Methadone Therapy. Clinical Pharmacology & Therapeutics. 116(4). 932–938. 9 indexed citations
3.
Gloor, Yvonne, et al.. (2024). Phenoconversion Due to Drug–Drug Interactions in CYP2C19 Genotyped Healthy Volunteers. Clinical Pharmacology & Therapeutics. 116(4). 1121–1129. 4 indexed citations
4.
Varesio, Emmanuel, et al.. (2024). Improving CYP2C19 phenotyping using stereoselective omeprazole and 5‐hydroxy‐omeprazole metabolic ratios. Basic & Clinical Pharmacology & Toxicology. 135(6). 755–766. 1 indexed citations
5.
Suppan, Mélanie, et al.. (2024). Enhancing Response Rates in Web-Based Surveys: The Impact of Direct Participant Contact. Healthcare. 12(14). 1439–1439. 3 indexed citations
6.
Terrier, Jean, et al.. (2024). The Impact of Dexamethasone and Prednisone on Apixaban and Rivaroxaban Exposure in COVID‐19 Patients: A Physiologically Based Pharmacokinetic Modeling Study. Clinical Pharmacology & Therapeutics. 117(2). 554–560. 3 indexed citations
7.
8.
Rodieux, Frédérique, Youssef Daali, Victoria Rollason, Caroline Samer, & Kuntheavy Ing Lorenzini. (2023). Practice of CYP450 genotyping and phenotyping in children in a real-life setting. Frontiers in Pharmacology. 14. 1130100–1130100. 2 indexed citations
9.
Samer, Caroline, et al.. (2023). Stereoselective separation of omeprazole and 5-hydroxy-omeprazole using dried plasma spots and a heart-cutting 2D-LC approach for accurate CYP2C19 phenotyping. Journal of Chromatography B. 1232. 123962–123962. 1 indexed citations
10.
Busse, Jason W., Alonso Carrasco‐Labra, Justin Durham, et al.. (2023). Management of chronic pain associated with temporomandibular disorders: a clinical practice guideline. BMJ. 383. e076227–e076227. 51 indexed citations
11.
Bueren, André O. von, et al.. (2023). Case report: Hepatotoxicity and nephrotoxicity induced by methotrexate in a paediatric patient, what is the role of precision medicine in 2023?. Frontiers in Pharmacology. 14. 1130548–1130548. 5 indexed citations
12.
Song, Wenyu, et al.. (2023). Polygenic risk scores in pharmacogenomics: opportunities and challenges—a mini review. Frontiers in Genetics. 14. 1217049–1217049. 15 indexed citations
13.
Gosselin, Pauline, Stéphane Guerrier, Youssef Daali, et al.. (2022). Dexamethasone exposure in normal‐weight and obese hospitalized COVID‐19 patients: An observational exploratory trial. Clinical and Translational Science. 15(7). 1796–1804. 8 indexed citations
14.
Samer, Caroline, Jérôme Stirnemann, Olivier Grosgurin, et al.. (2021). Electronic monitoring of potential adverse drug events related to lopinavir/ritonavir and hydroxychloroquine during the first wave of COVID-19. European Journal of Hospital Pharmacy. 30(2). 113–116. 6 indexed citations
15.
Gaudet-Blavignac, Christophe, et al.. (2020). Citizens’ Participation in Health and Scientific Research in Switzerland. Studies in health technology and informatics. 270. 1098–1102. 2 indexed citations
16.
Lorenzini, Kuntheavy Ing, et al.. (2020). Automatic Classification of Discharge Letters to Detect Adverse Drug Reactions. Studies in health technology and informatics. 270. 48–52. 3 indexed citations
17.
Girardin, François, Antoine Poncet, Arnaud Perrier, et al.. (2018). Cost-effectiveness of HLA-DQB1/HLA-B pharmacogenetic-guided treatment and blood monitoring in US patients taking clozapine. The Pharmacogenomics Journal. 19(2). 211–218. 29 indexed citations
18.
Mavrakanas, Thomas A., Caroline Samer, Sharon J. Nessim, Gershon Frisch, & Mark L. Lipman. (2017). Apixaban Pharmacokinetics at Steady State in Hemodialysis Patients. Journal of the American Society of Nephrology. 28(7). 2241–2248. 158 indexed citations
19.
Lorenzini, Kuntheavy Ing, Caroline Samer, Bertrand Guignard, et al.. (2012). Quel programme informatique de détection des interactions médicamenteuses néfastes. Revue Médicale Suisse. 8(358). 3 indexed citations
20.
Samer, Caroline, Youssef Daali, Michel Wagner, et al.. (2010). The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodone. British Journal of Pharmacology. 160(4). 907–918. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoseph Caraco Breakdown of academic impact, for papers by Mordechai Muszkat Breakdown of academic impact, for papers by C. Michael Stein Breakdown of academic impact, for papers by Daniel Kurnik Breakdown of academic impact, for papers by Hilary Wynne Breakdown of academic impact, for papers by René Verbesselt Breakdown of academic impact, for papers by Denis J. Morgan Breakdown of academic impact, for papers by Allan J. McLean Breakdown of academic impact, for papers by Jouni Ahonen Breakdown of academic impact, for papers by Hirotoshi Echizen
Rankless by CCL
2026